<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: GLPYY.PK News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=glpyy.pk</link><description>Latest Financial News for GALAPAGOS NV SP ADR</description><language>en-us</language><lastBuildDate>Wed, 16 Dec 2009 22:54:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Galapagos and GlaxoSmithKline Broaden Arthritis Alliance (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091216/0569998.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1247943483</guid><pubDate>Wed, 16 Dec 2009 22:54:00 Etc/GMT</pubDate></item><item><title>Galapagos Receives EUR 4 M Milestone for First Clinical Trial in GlaxoSmithKline Alliance (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091208/0566641.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3178245426</guid><pubDate>Tue, 8 Dec 2009 06:45:00 Etc/GMT</pubDate></item><item><title>Galapagos CEO increases shareholding (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091207/0566135.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2042780583</guid><pubDate>Mon, 7 Dec 2009 06:43:00 Etc/GMT</pubDate></item><item><title>Galapagos achieves multiple milestones in rheumatoid arthritis alliance (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091203/0565326.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/331653796</guid><pubDate>Thu, 3 Dec 2009 06:44:00 Etc/GMT</pubDate></item><item><title>Galapagos receives EUREKA innovation label and OSEO funding (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091126/0563159.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1860267830</guid><pubDate>Thu, 26 Nov 2009 07:23:00 Etc/GMT</pubDate></item><item><title>Galapagos initiates Nanocort(R) Phase II clinical trial for multiple sclerosis (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091117/0559973.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4102888579</guid><pubDate>Tue, 17 Nov 2009 06:41:00 Etc/GMT</pubDate></item><item><title>Galapagos Business Update (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091113/0558862.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1357146967</guid><pubDate>Fri, 13 Nov 2009 06:36:00 Etc/GMT</pubDate></item><item><title>Galapagos announces offering of new ordinary shares (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091015/0548033.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3625177427</guid><pubDate>Thu, 15 Oct 2009 18:25:00 Etc/GMT</pubDate></item><item><title>Galapagos expands strategic alliance in metabolic disease with Merck &amp; Co., Inc. (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091014/0547275.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3195903067</guid><pubDate>Wed, 14 Oct 2009 05:38:00 Etc/GMT</pubDate></item><item><title>Galapagos achieves first milestone in anti-infectives alliance with GlaxoSmithKline (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091007/0545000.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2332236547</guid><pubDate>Wed, 7 Oct 2009 05:35:00 Etc/GMT</pubDate></item><item><title>Galapagos announces expanded drug discovery collaboration with Schering-Plough (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090924/0540482.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2768908589</guid><pubDate>Thu, 24 Sep 2009 05:43:00 Etc/GMT</pubDate></item><item><title>Galapagos collaborates with Charley&apos;s Fund, Nash Avery Foundation to develop SARM candidate drug for Duchenne muscular dystrophy (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090917/0538111.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2560012365</guid><pubDate>Thu, 17 Sep 2009 05:36:00 Etc/GMT</pubDate></item><item><title>Galapagos initiates second Phase I clinical trial for GLPG0259 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090910/0535700.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/141409137</guid><pubDate>Thu, 10 Sep 2009 05:38:00 Etc/GMT</pubDate></item><item><title>Galapagos reports revenue growth and improved net result in 1H 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090807/0525977.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2803542401</guid><pubDate>Fri, 7 Aug 2009 15:03:00 Etc/GMT</pubDate></item><item><title>Galapagos Successfully Completes First Phase I Study for GLPG0259 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090806/0525411.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2635879385</guid><pubDate>Thu, 6 Aug 2009 05:43:00 Etc/GMT</pubDate></item><item><title>Galapagos achieves milestone in osteoporosis collaboration with Lilly (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090723/0521477.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1519213417</guid><pubDate>Thu, 23 Jul 2009 05:47:00 Etc/GMT</pubDate></item><item><title>Galapagos delivers second pre-clinical candidate in alliance with GlaxoSmithKline and receives EUR 5.2 million in milestone payments (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090707/0516637.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/902751608</guid><pubDate>Tue, 7 Jul 2009 05:43:00 Etc/GMT</pubDate></item><item><title>Galapagos Awarded Innovative Enterprise Qualification in France (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090630/0515155.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1399118513</guid><pubDate>Tue, 30 Jun 2009 05:36:00 Etc/GMT</pubDate></item><item><title>Galapagos Initiates Clinical Studies With GLPG0187, a Candidate Drug for Bone Metastasis (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090616/0510986.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1354806522</guid><pubDate>Tue, 16 Jun 2009 05:37:00 Etc/GMT</pubDate></item><item><title>Galapagos announces appointment of new CFO and Board Member; creates new warrant plan (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090603/0507224.html?.v=3</link><description></description><guid isPermaLink="false">yahoo_finance/1397267770</guid><pubDate>Wed, 3 Jun 2009 05:36:00 Etc/GMT</pubDate></item></channel></rss><!-- c19.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 23:22:09 PST 2009 -->
